Deniz Taşdemir

Dr. Deniz Taşdemir

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2026 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
DTDeniz Taşdemir
Deniz Taşdemir
MHMurat Haksever
Murat Haksever
Objective: The aim of this study was to investigate the association between maternal vitamin D status and fetal cortical maturation using detailed neurosonographic assessment at 28–30 weeks of gestation. Methods: This prospective observational study included 422 singleton pregnancies evaluated between 28 and 30 gestational weeks. Maternal serum 25-hydroxyvitamin D [25(OH)D] was measured by chemiluminescence immunoassay and categorized as deficient (30 ng/mL). Fetal neurosonography was performed with a GE Voluson E8 system to quantify sulcal depths (insula, Sylvian, parieto-occipital, calcarine, and cingulate fissures), corpus callosum thickness, cavum septum pellucidum length, operculization, and cortical maturation grades. Interobserver reliability, correlation, regression, and receiver operating characteristic (ROC) analyses were conducted. Results: Of 422 women, 280 (66.4%) were vitamin D deficient, 110 (26.1%) insufficient, and 32 (7.6%) sufficient. Deficient participants showed significantly lower mean insula, parieto-occipital, and calcarine fissure depths and thinner corpus callosum (p < 0.05). Operculization and cortical maturation grades were also reduced (p = 0.02 and p = 0.01, respectively). Maternal 25(OH)D levels positively correlated with calcarine fissure depth (r = 0.42, p < 0.001) and cortical maturation grade (r = 0.45, p < 0.001). After adjustment for gestational age, vitamin D deficiency independently predicted low cortical maturation (≤ grade 3) (adjusted OR 2.56, 95% CI: 1.34–4.89, p = 0.004). ROC analysis demonstrated good discriminatory ability (AUC = 0.74, p < 0.001), with an optimal vitamin D threshold of ≈ 21 ng/mL yielding 78% sensitivity and 65% specificity. Conclusion: Maternal vitamin D deficiency during the late second to early third trimester is associated with delayed fetal cortical sulcation and reduced operculization grades. Quantitative neurosonography can noninvasively identify early neurodevelopmental vulnerability related to suboptimal maternal vitamin D status, supporting the role of adequate vitamin D as a modifiable determinant of fetal brain development. Given the high prevalence of hypovitaminosis D observed in this cohort, assessment of maternal 25(OH)D levels may be justified in high-risk or high-prevalence populations. Based on commonly applied clinical thresholds, supplementation of approximately 600 IU/day for vitamin D-sufficient women, 1,000 IU/day for those with insufficiency, and 1,500–2,000 IU/day for deficient women may be considered.

5 February 2026 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
DTDeniz Taşdemir
Deniz Taşdemir
Background and objectives: To assess the association between maternal Ramadan fasting and fetal cardiac function and hemodynamics using comprehensive Doppler echocardiography, with a focus on subclinical myocardial and circulatory changes. Materials and methods: In this cross-sectional Doppler ultrasound study, 203 healthy singleton pregnancies between 24 and 32 weeks of gestation were examined, comprising 102 women who fasted for ≥ 10 days during Ramadan and 101 non-fasting controls. The study was prospectively registered with the National Clinical Trial ( ClinicalTrials.gov Identifier: NCT06900257, registration date 23 March 2025). Doppler assessments included umbilical artery, middle cerebral artery, and ductus venosus pulsatility indices (PI), cerebroplacental ratio, and fetal cardiac parameters, including left and right myocardial performance indices (LV MPI, RV MPI), tricuspid and mitral annular plane systolic excursions (TAPSE, MAPSE), cardiothoracic ratio (CTR), and amniotic fluid index (AFI). Statistical analyses were performed using IBM SPSS v25.0 and Python 3.10, including group comparisons, correlation analysis, multivariable regression, and receiver operating characteristic (ROC) analysis. Results: Fasting pregnancies demonstrated significantly higher MCA PI ( p < 0.001), LV MPI ( p < 0.001), RV MPI ( p = 0.041), and CTR ( p < 0.001), and lower AFI ( p < 0.001) than controls. Umbilical and ductus venosus PI, TAPSE, and MAPSE did not differ significantly.LV MPI correlated positively with CTR (r = 0.33) and inversely with AFI (r = –0.42). In multivariable regression analysis, fasting status was independently associated with higher LV MPI and lower AFI. ROC analysis demonstrated that LV MPI had no clinically meaningful predictive value for low amniotic fluid volume (AUC = 0.52). Conclusions: Maternal Ramadan fasting was associated with mild differences in fetal cardiac and hemodynamic parameters, characterized by increased MPI and MCA PI and reduced AFI, without overt Doppler evidence of fetal distress. These findings highlight the adaptive capacity of the fetal cardiovascular system; however, given the cross-sectional design, causality and reversibility cannot be established, but support individualized monitoring during fasting in pregnancy. Trial registration: ClinicalTrials.gov Identifier NCT06900257. Registered on 23 March 2025. (The record currently appears as “Update Not Released” on ClinicalTrials.gov due to the temporary U.S. government shutdown, but the submission has been completed and will be publicly released once the database reopens.)


17 October 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
DTDeniz Taşdemir
Deniz Taşdemir
MHMurat Haksever
Murat Haksever
SKSelim Kandemir
Selim Kandemir
BKBekir Kahveci
Bekir Kahveci
RŞRefaettin Şahin
Refaettin Şahin
IHIsmet Hortu
Ismet Hortu
Objective: To explore the incremental prognostic information of fetal Doppler measurements beyond maternal and fetal biometric characteristics for adverse perinatal outcomes in pregnancies with suspected fetal smallness. Methods: This retrospective cohort study included 606 singleton pregnancies assessed for suspected or diagnosed fetal growth restriction. The principal analysis was restricted to 429 pregnancies with estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile at the index examination. A composite adverse perinatal outcome comprised five-minute Apgar score < 7, umbilical arterial pH < 7.10, neonatal intensive care unit (NICU) admission, respiratory support, neonatal death, or stillbirth. Baseline clinical–biometric, Doppler-integrated, and delivery-week sensitivity logistic models were assessed using stratified 10-fold out-of-fold predictions. Additional robustness analyses evaluated component frequencies, a hard-outcome sensitivity composite less directly influenced by clinical management, paired uncertainty in out-of-fold performance differences, and model performance across alternative cohort definitions. Results: Among 429 pregnancies in the principal cohort, 111 (25.9%) met the composite adverse perinatal outcome, and 206 (48.0%) had abnormal Doppler findings. Event rates were 85/206 (41.3%) among pregnancies with abnormal Doppler and 26/223 (11.7%) among those with normal Doppler. The baseline and Doppler-integrated out-of-fold areas under the receiver operating characteristic curve (AUCs) were 0.642 and 0.690, respectively; corresponding Brier scores were 0.183 and 0.174. Elevated umbilical artery pulsatility index with forward flow and absent or reversed end-diastolic flow (AEDF/REDF) were independently associated with the composite outcome, with adjusted odds ratios of 2.61 (95% confidence interval [CI], 1.58–4.32) and 6.60 (95% CI, 2.40–18.18), respectively, compared with normal umbilical artery flow. The adjusted estimate for the AEDF/REDF subgroup was imprecise because this subgroup included only 19 pregnancies. The paired out-of-fold AUC increment for the Doppler-integrated model was 0.049 (95% CI, 0.005–0.094); the corresponding Brier-score improvement was 0.009 (95% CI, −0.0004 to 0.0179). Sensitivity analyses supported a modest incremental contribution but did not establish the superiority of the integrated model over alternatives based on the cerebroplacental ratio (CPR) or umbilical artery (UA) Doppler. Conclusions: In pregnancies with suspected fetal smallness defined by EFW or AC below the 10th percentile, fetal Doppler assessment provided modest incremental prognostic information beyond maternal and fetal biometric characteristics. Umbilical artery abnormalities were associated with the composite adverse perinatal outcome, although this association should be interpreted in the context of delivery timing and clinical management. External validation and assessment of clinical utility are required before clinical implementation of the model.

12 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MHMurat Haksever
Murat Haksever
DTDeniz Taşdemir
Deniz Taşdemir
SKSelim Kandemir
Selim Kandemir
BKBekir Kahveci
Bekir Kahveci
RŞRefaettin Şahin
Refaettin Şahin
IHIsmet Hortu
Ismet Hortu
Background/Objectives: Preeclampsia is a heterogeneous hypertensive disorder of pregnancy, and accessible hematologic indices may reflect maternal physiologic differences before the clinical syndrome becomes evident. This study evaluated whether the first-trimester hemoglobin-to-red cell distribution width (Hb/RDW) ratio was associated with later documented preeclampsia and assessed its discrimination, relation to disease severity, and association with maternal–neonatal outcomes in a tertiary-care cohort. Methods: This retrospective cohort study included 224 singleton pregnancies managed at a tertiary referral center between January 2024 and December 2025. Data extraction, anonymization, and analysis were performed after ethics approval (Approval No. 72; 2 March 2026). Participants were categorized as preeclampsia-negative (n = 131) or preeclampsia-positive (n = 93). Preeclampsia and severe features were defined according to American College of Obstetricians and Gynecologists criteria. The Hb/RDW ratio was calculated from routine first-trimester complete blood count parameters obtained before clinical diagnosis or final outcome classification. ROC analysis, multivariable logistic regression, multicollinearity assessment, events-per-variable evaluation, calibration testing, and exploratory incremental discrimination analyses were performed. Results: The first-trimester Hb/RDW ratio was higher in pregnancies later complicated by preeclampsia. Single-marker ROC analysis showed moderate discrimination (AUC = 0.687; bootstrap 95% CI: 0.618–0.755). At the 0.63 cut-off, sensitivity was 89.2%, specificity 47.3%, positive predictive value 54.6%, and negative predictive value 86.1%. In the primary multivariable model, Hb/RDW remained associated with later preeclampsia (adjusted OR per 0.1-unit increase = 1.45; 95% CI: 1.22–1.72; p < 0.001). However, Hb/RDW was not independently associated with severe preeclampsia among affected patients, fetal growth restriction, or composite maternal morbidity. VIF values ranged from 1.00 to 1.07. Secondary models for fetal growth restriction and composite maternal morbidity had borderline events-per-variable values and were interpreted as exploratory. Conclusions: First-trimester Hb/RDW was associated with later documented preeclampsia in this retrospective tertiary-care cohort, but its single-marker performance was modest and specificity was limited. The ratio should be interpreted as an inexpensive research marker of hematologic phenotype rather than a stand-alone screening, diagnostic, or management tool. Prospective multicenter validation with standardized first-trimester sampling and adjustment for hematinic and nutritional variables is required before clinical implementation.

25 October 2026 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
MHMurat Haksever
Murat Haksever
DTDeniz Taşdemir
Deniz Taşdemir
RŞRefaettin Şahin
Refaettin Şahin
Aims: To compare the diagnostic performance of biochemical risk assessment alone with that of a multimarker first-trimester risk assessment combining biochemical and sonographic parameters for screening of fetal chromosomal anomalies. Methods: This retrospective observational study included singleton pregnancies evaluated at a tertiary perinatology clinic between January 2022 and January 2026. Pregnancies undergoing first-trimester screening at 11+0 to 13+6 weeks of gestation were included. Biochemical risk was calculated using maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A, whereas multimarker risk was derived from maternal characteristics, biochemical markers, and sonographic findings, including nuchal translucency and selected additional markers when available. The primary outcome was confirmed fetal chromosomal anomaly. Diagnostic indices and receiver operating characteristic (ROC) analyses were performed. Results: A total of 1,248 singleton pregnancies were analyzed, including 42 fetuses (3.4%) with chromosomal anomalies. Compared with the biochemical model, the multimarker model showed higher sensitivity (81.0% vs 69.0%), specificity (95.7% vs 92.6%), positive predictive value (39.5% vs 24.6%), and overall accuracy (95.2% vs 91.8%). The false-positive rate was lower with the multimarker approach (4.3% vs 7.4%). ROC analysis demonstrated superior discriminative performance for the multimarker model (AUC: 0.903 vs 0.812, p<0.001). Conclusion: Multimarker first-trimester risk assessment provided better overall diagnostic performance than biochemical risk assessment alone, particularly in terms of specificity, accuracy, and reduction of false-positive results. These estimates should be interpreted in light of the retrospective design, partial verification bias, and the limited number of affected pregnancies.